
doi: 10.1093/cid/ciaf147
pmid: 40117207
Abstract The impact of glucocorticoids, comorbid conditions, and immunosuppressive therapies on Pneumocystis jirovecii pneumonia risk remains understudied, and prophylaxis is underused. Among US adults in TriNetX prescribed glucocorticoids for ≥2 weeks, 44.6% received >20 mg prednisone equivalents daily. Prophylaxis rates were low, with higher glucocorticoid doses associated with lower prophylaxis odds.
Male, Adult, Pneumonia, Pneumocystis, Middle Aged, Antibiotic Prophylaxis, Pneumocystis carinii, United States, Immunocompromised Host, Humans, Prednisone, Female, Glucocorticoids, Immunosuppressive Agents, Aged
Male, Adult, Pneumonia, Pneumocystis, Middle Aged, Antibiotic Prophylaxis, Pneumocystis carinii, United States, Immunocompromised Host, Humans, Prednisone, Female, Glucocorticoids, Immunosuppressive Agents, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
